NEW YORK (GenomeWeb) — Transgenomic reported today that its third quarter revenues declined 3 percent year over year due to a decrease in sales in both its laboratory services and genetic assays and platform segments.
Nabsys said that Anthony Shuber has joined the company as vice president and chief scientific officer. He comes to Nabsys from Ignyta, an oncology precision medicine firm, where he served as chief technology officer.
NEW YORK (GenomeWeb) — Researchers at the University of Pittsburgh Medical Center have received funding to begin translating animal studies linking environmental toxin exposure and Parkinson's disease pathology to human samples.
NEW YORK (GenomeWeb) — Transgenomic said today that it has signed a licensing deal with the Dana-Farber Cancer Institute for exclusive worldwide rights to develop and commercialize multiplexed versions of its ICE COLD-PCR technology.
Researchers affiliated with the laboratory of Mike Makrigiorgos at Dana Farber Cancer Institute and Harvard Medical School have demonstrated how their COLD-PCR method can be applied to epigenetics, allowing the enrichment and sequencing of rare unmethylated DNA regions in a background of highly m